CDW vs GRCE · P/E 22, rev $21.00B vs $35.0M cap
CDW Corp (CDW) versus Grace Therapeutics, Inc. (GRCE) — a side-by-side from cached financials, not a winner call.
CDW Corp (CDW) is a information technology services company listed on US.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
GRCE does not have a complete income-statement cache yet.
CDW currently screens at market cap $23.36B and trailing P/E 22.0. GRCE currently screens at market cap $35.0M.
Not investment advice. Open the CDW and GRCE stock pages for the full models.
Not investment advice.